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The new millennium has witnessed the emergence of the epidemic 
of non-communicable diseases, with frightful consequences to 
the	health	of	people	world‑wide.	Insulin	resistance	(IR),	defined	
as a reduced biological action of insulin, has emerged as a major 
pathophysiological factor in the development and progression 
of a number of common non-communicable diseases in man 
including type 2 diabetes mellitus, polycystic ovary disease, 
dyslipidemia, hypertension, cardiovascular disease, sleep apnea, 
certain hormone-sensitive cancers and obesity.[1,2]
The concept of IR was proposed as early as 1936[3] and is 
generally	defined	as	decreased	sensitivity	or	responsiveness	
to the metabolic actions of insulin, such as insulin-mediated 
glucose disposal and inhibition of hepatic glucose production.[4]
IR is probably the unifying pathophysiological denominator of 
a cluster of non-communicable disease risk factors including 
elevated plasma glucose, lipid regulation problems 
(elevated triglycerides increased small low-density lipoproteins 
and decreased high-density lipoproteins), hypertension and 
obesity. This combination is referred to as either “the metabolic 
syndrome (MS)” or “syndrome X” or “IR syndrome”.[1]
A	lack	of	accepted	criteria	and	in	cognizance	of	the	difficulty	
in using a surrogate marker (hyperinsulinemia) for IR in 
clinical practice, the World Health Organization in 1998, more 
recently NCEP-ATP III [The National Cholesterol Education 
Program (NCEP) Expert Panel on Detection, Evaluation, And 
Treatment of High Blood Cholesterol In Adults (Adult Treatment 
Panel III)], proposed the use of a group of lipid and non-lipid risk 
factors of metabolic origin, which are closely linked to IR.[5,6]
In the Indian context, the increasing tendency of its inhabitants 
to develop MS due to genetic predispositions and change 
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of life-style due to the impact of westernization and rapid 
urbanization, has led the people to become more vulnerable 
to developing IR.[7]
The gold standard test for evaluating IR is the euglycemic 
hyperinsulinemic clamp in which after overnight fast, insulin is 
infused intravenously at a constant rate and glucose is infused 
intravenously at a variable rate to maintain constant glucose 
concentrations. Its use is limited to clinical practice owing 
to the time and cost involved.[8] For this reason, simpler, less 
invasive techniques of determining IR like Homeostatic model 
assessment (HOMA) have been developed. The technique 
is a method for assessing β-cell function and IR from basal 
glucose and insulin or C-peptide concentrations.[9] The 
original	model	HOMA1‑IR,	first	demonstrated	by	Matthews	
et al. (1985),[10] has been widely used, especially in different 
epidemiological and clinical studies. However, the model was 
updated with some physiological adjustments to a computer 
version (HOMA2-IR) providing a more accurate index.[11]
Though, available literature amply illustrates the correlation 
of IR with metabolic risk factors limited data is available of 
its prevalence in the state of Bihar. Keeping this in mind, the 
present	study	was	undertaken	to	find	out	the	magnitude	of	IR	
and its associated metabolic risk factors among the patients 
attending the outpatient clinic of the Mata Gujri Memorial 
Medical College and LSK Hospital, Kishanganj, Bihar.
Subjects and Methods
A hospital-based cross-sectional study was conducted among 
purposively selected 112 apparently healthy individuals aged 
20 years and above, attending the out-patient clinic of the 
Mata Gujri Memorial and LSK Hospital, Kishanganj, during 
the period of June 2010 to November 2010. Participants 
were informed about the purpose of the study and those who 
gave their consent were requested to visit the hospital on 
pre‑specified	dates	 for	blood	 testing	after	 an	overnight	 fast	
for 12 h. Patients with previously diagnosed cardiovascular 
diseases, diabetes mellitus, renal failure, hyperuricemia were 
excluded from the study. All participants were interviewed by 
using a pre-tested, pre-designed standard questionnaire that 
evaluated various socio-demographic, clinical and biological 
characteristics including age, gender, weight, height, waist 
circumference and blood pressure (BP).
Biophysical parameters
Body weight was measured by portable weighing machine 
setting the pointer at zero reset with the subject wearing 
light clothes and without shoes. Height was recorded during 
inspiration using a standardized self-rolling steel plate to 
the nearest 0.5 cm. Body mass index (BMI) was calculated 
by dividing the weight of an individual in kilogram by 
the square of his/her height measured in meters; and was 
categorized as per as per Indian Council of Medical Research 
classification (normal: 18.5-22.9 kg/m2, overweight: 
23-24.99 kg/m2,	obesity:	≥25	kg/m2).[12] BP was recorded using 
the standard mercury sphygmomanometer with adult size cuff 
in	palpatory	method	first	 then	 the	auscultatory	method	 in	a	
sitting posture. Three measurements were taken at the interval 
of 5 min; the mean value was taken among the three systolic 
BP and diastolic BP respectively. Waist circumference was 
assessed at the end of expiration, measuring the minimum 
circumference at the level of the umbilicus to the nearest 
0.1 cm. For measurement in female subjects, a female attendant 
was taken to stand by the side.
Biochemical measurements
The blood samples were collected from the antecubital vein 
after 12 h of fasting and avoiding of alcohol. The level of 
serum glucose, high density lipoprotein cholesterol (HDL-C), 
triglyceride, were measured by Erba CHEM-5 Plus V2 
auto-analyzer [Transasia Bio-Medicals Ltd]. The plasma 
sugar was determined using the glucose oxidase enzymatic 
method (Trinder, 1969). Triglyceride concentration was 
determined with a semi-automated enzymatic analyzer (RA 
50, Semi-auto Chemistry Analyzer, Thyrocare India Ltd., 
India). Serum HDL-C level was measured by using the 
phosphotungstate precipitation method. Plasma C-reactive 
protein (CRP) was estimated using the latex slide test based 
on an immunologic reaction between CRP as an antigen and 
latex	 particles	 coated	with	 non‑specific	 anti	 human	CRP	
and is sensitized to detect levels greater than 6 µg/ml CRP. 
C-peptide was estimated by Acculite™ chemiluminescence 
immuno assay (CLIA) test system based on CLIA method. An 
internal quality control was in place for assessing the validity 
of glucose, triglyceride and HDL methods.
MS and IR
The International Diabetes Federation criteria[13] was used to 
define	MS.	Insulin	sensitivity	was	assessed	by	the	calculation	
of the HOMA approach. The HOMA2-IR index was obtained 
by the program HOMA-Calculator version 2.22 [http://www.
dtu.ox.ac.uk/] taking into consideration both fasting C-peptide 
and fasting plasma glucose level.[11]
Statistical analyses
Continuous variables are presented as mean values 
(standard deviation), while qualitative variables are presented 
as relative frequencies. Comparisons between normally 
distributed continuous variables and categorical were 
performed by the calculation of Student’s t-test and one-way 
or multi-way analysis of variance, after testing for equality 
of variances (homoscedasticity) using IBMSPSS [Statistical 
Package for the Social Sciences] version 20 software 
(Chicago, IL, USA). Linear regression analysis was carried 
out using constant, waist circumference, serum HDL-C, 
systolic BP in mm of Hg, fasting blood glucose, serum 
triglycerides, diastolic BP in mm of Hg as predictor variables 
and HOMA2-IR as the dependent variable. All reported 
P values are based on two-sided tests and compared with a 
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Relationship between components of MS and IR
From the regression results, it was observed that among the 
components of MS, waist circumference had the highest 
contribution toward the dependent variable IR, followed by 
serum triglycerides, fasting blood glucose, serum HDL-C, 
systolic BP in mm of Hg and lastly, diastolic BP in mm of Hg. 
The regression model for this purpose can be best expressed 
as follows:
IR	=	−2.169	+	 0.26	 (waist	 circumference)	 +0.008	 (serum	
triglycerides) +0.004 (serum HDL-C) +0.005 (fasting blood 
glucose)	+0.003	(systolic	BP	in	mm	of	Hg)	−0.001	(diastolic	
BP in mm of Hg).
Applying the above model, 38.9% of the total variation of 
IR can be predicted using the variables waist circumference, 
serum HDL-C, systolic BP in mm of Hg, fasting blood 
glucose, serum triglycerides, diastolic BP in mm of 
Hg [Table 3].
Areas under ROC curves (95% confidence interval [CI]) 
to predict IR using HOMA2‑IR
Figure 1 shows that HOMA2-IR index presented area under 
the curve of 0.834 with overlapping 95% CI of 0.758-0.909. 





IR has been suggested as the primary cause leading to 
the clustering of risk factors such as glucose intolerance, 
hypertension, elevated serum triglycerides, low serum 
HDL-C and central obesity which together have been 
labeled as MS.[14] Direct measurement of IR using the 
hyperinsulinemic-euglycemic clamp is the gold standard, 
but it has limited practical application. Previous studies have 
shown that HOMA-IR based IR measurements have a strong 
correlation with glucose clamp-assessed IR.[10,15]
significance	level	of	5%.	SPSS	version	16.0	was	used	for	all	
statistical analyses.
The cut-off values for IR were based on the 90th percentile in the 
study population and a receiver operating characteristic (ROC) 
curve was generated. The area under the ROC curve was 
calculated to evaluate the accuracy of the HOMA2-IR index. 
The optimal cut-off value was denoted by the value that had 
the	largest	sum	of	sensitivity	and	specificity.
Informed consent was obtained from the participants. 
Participation in the study was voluntary and guarantee 
of confidentiality and anonymity of data was ensured. 
Ethical clearance was obtained from the Institutional Ethics 
Committee.
Results
Background factors of subjects categorized by sex
Among the 112 individuals who participated in the study, 
there were 43 males and 69 females. The mean and standard 
deviation of both biological and biochemical parameters 
between males and females were calculated and presented 
in Table 1. Males had a higher waist circumference, diastolic 
BP while females had a higher BMI, systolic BP, serum HDL, 
CRP and C-peptide levels. The parameters for assessment of 
IR by HOMA2-IR among the study population were studied 
and it was found that the fasting plasma glucose had a mean 
91.7 (18.9) and C-peptide had mean 2.1 (1.8). HOMA2-IR 
calculated from these indices shows mean 1.5 (1.0).
IR of subjects categorized by BMI, CRP and MS
It is evident from Table 2 that the mean IR using HOMA2-IR 
in individuals with normal BMI was 1.1 (0.4) and 2.2 (0.8) 
among	the	obese;	2.0	(0.9)	among	those	with	CRP	≥6	mg/l	
and 2.3 (1.0)± in persons with MS. Distribution of IR 
using	HOMA2‑IR	varies	 significantly	with	BMI,	CRP	and	
occurrence	 of	MS	 and	 there	 is	 no	 statistically	 significant	
difference in mean and standard deviation of IR (HOMA2-IR) 
among males (1.5 [1.1)]) and females (1.7 [0.8]).
Table 1: Biological and biochemical parameters of the study population (n=112)
Parameters Male (n=43) Female (n=69) Total P value*
Age 42.6 (13.92) 42.8 (14.41) 42.7 (14.12) P=0.95
BMI (kg/m2) 21.9 (3.81) 24.4 (7.21) 23.4 (6.23) P=0.04
Waist circumference (cm) 83.3 (11.01) 79.0 (12.61) 80.7 (12.24) P=0.06
Fasting blood glucose (mg/dl) 91.9 (23.53) 91.5 (15.62) 91.7 (18.91) P=0.92
Systolic blood pressure (mm of Hg) 122.9 (27.21) 126.1 (21.83) 124.9 (24.01) P=0.49
Diastolic blood pressure (mm of Hg) 80.1 (8.43) 77.4 (13.14) 78.5 (11.61) P=0.19
Triglycerides (mg/dl) 106.2 (51.14) 106.6 (42.81) 106.4 (45.90) P=0.96
HDL (mg/dl) 33.0 (6.24) 39.2 (6.61) 36.8 (7.11) P<0.001
Serum C‑peptide 2.0 (1.92) 2.1 (0.82) 2.1 (1.32) P=0.55
CRP 2.5 (2.61) 3.6 (8.01) 3.2 (6.52) P<0.01
Insulin resistance by HOMA2‑IR 1.5 (1.11) 1.7 (0.82) 1.5 (1.03) P=0.22
Data presented mean±SD. *P value from Student’s t-test for continuous normally distributed variables; Mann-Whitney U-test for skewed distributions. HOMA: Homeostatic model assessment, 
SD: Standard deviation, BMI: Body mass index, HDL: High density lipoprotein, CRP: C-reactive protein
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calculated by HOMA2-IR was 1.5 (1.0) which was very close 
to	 the	findings	of	 the	study	among	Pakistani	subjects	using	
HOMA-IR method by Hydrie et al. (1.6 [0.8]).[16]
In a study, among 1525 Peruvian adults by Gelaye et al., it 
was found that the mean value of waist circumference, systolic 
and diastolic BP, triglycerides were significantly higher 
among	males.	Women	had	significantly	higher	mean	age	and	
high	density	lipoprotein‑cholesterol;	there	was	no	significant	
gender difference in the values of CRP, fasting insulin and 
fasting glucose.[17]
In the present study, the gradient of IR has increased 
significantly	with	increasing	categories	of	BMI	and	CRP.	CRP,	
a	systemic	inflammatory	marker,	when	measured	in	the	blood	
with high sensitivity assay has been reported to be a strong and 
independent predictor of future cardiovascular disease (CVD) 
risk including IR.[18,19]
Gelaye et al.[17] in their study demonstrated elevated CRP 
levels	 significantly	 associated	with	 increased	mean	 fasting	
insulin and mean HOMA-IR concentrations, whereas, in a 
study done by Moran et al. among the youths of Minneapolis, 
CRP levels in children age 10-16 years were found not to be 
significantly	associated	with	IR.[20] On the other hand, Vikram 
et al. in a study among the urban young adult north Indian 
males, failed to show any correlation between highly sensitive 
CRP and IR.[21]
The relationship of obesity to IR and type 2 diabetes is a 
long-recognized phenomenon with fundamentally important 
In the present study, IR was calculated by HOMA2-IR method, 
which is a more accurate representation of metabolic process 
because it models the feedback relationship between insulin 
and glucose in various organs of the body.[9]
The present study demonstrated the magnitude of IR and its 
associated metabolic risk factors among the 112 attendees of 
an out-patient department of a tertiary care hospital. There 
were 43 males and 69 females and the mean age of the study 
population were 45.9 (13.6) years.
The differences between males and females were evident in 
the study population despite similarities in mean age, fasting 
blood glucose, triglycerides and C-peptide. The mean IR as 
Table 2: Distribution of insulin resistance using HOMA2‑IR 
among the study population (n=112)
Variables n HOMA2‑IR Test
Mean SD
BMI
 Normal 52 1.07 0.43 F=24.753, P<0.001
 Overweight 22 1.97 1.25
 Obese 38 2.18 0.82
CRP
 <6 mg/l 87 1.52 0.91 t=−2.228, P=0.03
 ≥6 mg/l 25 1.99 0.95
MS
 Yes 41 2.36 1.05 t=6.646, P<0.001
 No 71 1.20 0.51
HOMA: Homeostatic model assessment, IR: Insulin resistance, SD: Standard deviation, 
BMI: Body mass index, CRP: C-reactive protein, MS: Metabolic syndrome












0.834 <0.001 0.758‑0.909 1.35 90.2% 71.8%
Figure  1: Receiver operating characteristics curve of homeostatic 
model assessment 2 insulin resistance to predict insulin resistance
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scientific	and	clinical	implications.[22] Changes in BMI were 
found to be positively correlated with changes in IR in a study 
among black and white adolescent girls by Auwerx et al. 
(P < 0.001)[23] and in healthy Brazilian subjects by Geloneze 
et al.[24] which was in consonance with the present study. In 
contrast, in a study among Sri Lankan diabetic population, 
a negative correlation was found between BMI and IR by 
HOMA-IR.[25]
According to Reaven, IR is the central pathophysiological 
feature of the cluster of metabolic abnormalities, which are 
associated with MS.[14] Globally, several studies have suggested 
that subjects with MS are more insulin resistant and are at 
increased risk for CVD than those without MS[26,27] which are 
similar	to	the	findings	of	the	present	study.
Finally,	to	confirm	whether	the	risk	factors	could	be	attributed	
to enhanced IR, HOMA-IR in comparison with those of MS 
components (waist circumference, fasting blood glucose, 
systolic BP/diastolic BP, serum triglycerides and HDL-C) were 
examined and it was observed that serum triglycerides and 
waist	circumference	were	significantly	related	to	IR.	Similar	
findings	were	observed	by	Yamada	et al.[28] and Kawamoto 
et al.[29] among the Japanese population.
The presence of hypertriglyceridemia always associated with 
IR in these studies may be due to the fact that insulin affects 
triglyceride and HDL-C metabolism.[30]
Determining cut-off values of IR by indirect measures could 
help in identifying insulin resistant subjects in clinical practice 
on account of their simplicity and clinicians may be able to 
use this simple test as an initial screening tool to identify such 
subjects in the future. The ROC curve [Figure 1] in the present 
study depicts that the optimal cut-off value to detect IR by 
HOMA2-IR was 1.35. The optimal cut-off value to detect IR 
was 1.8 among Brazilian population[24] and 1.67 among the 
Argentinean population.[26]
The	strength	of	 the	 study	 is	 that	 it	 is	one	of	 the	first	 study	
in this part of the country which measures IR based on 
HOMA2-IR among apparently healthy individuals. However, 
the limitations of our study must also be considered. The 
number of subjects studied was very small and they may 
not be representative of the general population. Due to the 
cross-sectional nature of the present study, the cause-effect 
relationship	of	our	findings	cannot	be	proven	and	a	large	scale,	
prospective study is required.
Conclusion
The	findings	of	the	present	study	reveal	that	IR	is	associated	
with various clinico-metabolic risk factors. In conclusion, IR 
can be viewed as a large iceberg where unknown morbidity 
exceeds the known morbidity. The physician recognizes 
only the clinically evident manifestations which reflect 
only the proverbial “tip of the iceberg” - diabetes, obesity, 
hypertriglyceridemia, hypertension, diminished HDL 
cholesterol and atherosclerosis – and the complete IR syndrome 
may be missed. With the recognition that IR is a multifaceted 
syndrome that can express itself in many ways, it is important 
for	the	scientific	community	to	focus	their	attention	on	defining	
the mechanism (s) responsible for this defect.
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